{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T06:54:31Z","timestamp":1771656871777,"version":"3.50.1"},"reference-count":135,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.clml.2023.08.019","type":"journal-article","created":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T01:58:57Z","timestamp":1693187937000},"page":"15-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Multiple Myeloma in Young Patients: A Scoping Review"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9444-7166","authenticated-orcid":false,"given":"Mary","family":"Steinbach","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karun","family":"Neupane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Aziz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wade","family":"Lee-Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelley","family":"Julian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amandeep","family":"Godara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"McClune","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amar H.","family":"Kelkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas","family":"Sborov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghulam Rehman","family":"Mohyuddin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2023.08.019_bib0001","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/ajh.26590","article-title":"Multiple myeloma: 2022 update on diagnosis, risk stratification, and management","volume":"97","author":"Rajkumar","year":"2022","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2023.08.019_bib0002","first-page":"257","article-title":"Post relapse outcomes in young patients with multiple myeloma in the era of novel agents","volume":"100","author":"Vallumsetla","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2023.08.019_bib0003","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1053\/j.seminoncol.2016.11.004","article-title":"Multiple myeloma epidemiology and survival: a unique malignancy","volume":"43","author":"Kazandjian","year":"2016","journal-title":"Semin Oncol"},{"key":"10.1016\/j.clml.2023.08.019_bib0004","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.htct.2020.06.014","article-title":"Young age and autologous stem cell transplantation are associated with improved survival in newly diagnosed multiple myeloma","volume":"43","author":"Bove","year":"2021","journal-title":"Hematol Transfus Cell Ther"},{"key":"10.1016\/j.clml.2023.08.019_bib0005","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1001\/archinte.1996.00440120125014","article-title":"Multiple myeloma in patients younger than 30 years: report of 10 cases and review of the literature","volume":"156","author":"Blade","year":"1996","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clml.2023.08.019_bib0006","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1046\/j.1365-2141.1996.5191061.x","article-title":"Presenting features and prognosis in 72 patients with multiple myeloma who were younger than 40 years","volume":"93","author":"Blad\u00e9","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2023.08.019_bib0007","first-page":"522","article-title":"The Swedish multiple myeloma register: median 5-year survival of 7.3 years in patients 65 years and younger, population-based data on 3,876 multiple myeloma patients diagnosed 2008-2013","volume":"101","author":"Blimark","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2023.08.019_bib0008","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1182\/blood-2007-08-104984","article-title":"Recent major improvement in long-term survival of younger patients with multiple myeloma","volume":"111","author":"Brenner","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.clml.2023.08.019_bib0009","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1182\/blood.V128.22.4774.4774","article-title":"Recent trends in multiple myeloma incidence and survival by age, race and ethnicity in the US","volume":"128","author":"Costa","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.clml.2023.08.019_bib0010","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1182\/blood.V122.21.5359.5359","article-title":"Multiple myeloma in patients under 40 years old is associated with high-risk features and worse outcomes","volume":"122","author":"Costello","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.clml.2023.08.019_bib0011","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1182\/blood-2020-140718","article-title":"The relative risk of prognostic factors of age stratified multiple myeloma","volume":"136","author":"Du","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.clml.2023.08.019_bib0012","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/hon.2379","article-title":"Efficacy and safety of high-dose chemotherapy with autologous stem cell transplantation in senior versus younger adults with newly diagnosed multiple myeloma","volume":"35","author":"Huang","year":"2017","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.clml.2023.08.019_bib0013","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41408-022-00671-z","article-title":"Financial toxicity in hematological malignancies: a systematic review","volume":"12","author":"Ouchveridze","year":"2022","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.clml.2023.08.019_bib0014","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ejon.2014.10.003","article-title":"Disease isolation: the challenges faced by mothers living with multiple myeloma in rural and regional Australia","volume":"19","author":"Wagland","year":"2015","journal-title":"Eur J Oncol Nurs"},{"key":"10.1016\/j.clml.2023.08.019_bib0015","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.6004\/jnccn.2020.7561","article-title":"Symptom burden, perceived control, and quality of life among patients living with multiple myeloma","volume":"18","author":"Zaleta","year":"2020","journal-title":"J Natl Compr Cancer Netw"},{"issue":"suppl 1","key":"10.1016\/j.clml.2023.08.019_bib0016","first-page":"S7","article-title":"Trends of incidence and survival of multiple myeloma in the adolescent and young adult (AYA) population in the US","volume":"95","author":"Cherukuri","year":"2020","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2023.08.019_bib0017","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s002770050365","article-title":"Multiple myeloma in younger patients: the role of age as prognostic factor","volume":"76","author":"Corso","year":"1998","journal-title":"Ann Hematol"},{"key":"10.1016\/j.clml.2023.08.019_bib0018","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.soncn.2017.05.007","article-title":"Young adults with multiple myeloma","volume":"33","author":"Devine","year":"2017","journal-title":"Semin Oncol Nurs"},{"key":"10.1016\/j.clml.2023.08.019_bib0019","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1182\/asheducation-2018.1.97","article-title":"Treatment approach for young, fit, newly diagnosed multiple myeloma patients","volume":"2018","author":"Usmani","year":"2018","journal-title":"Hematology (United States)"},{"key":"10.1016\/j.clml.2023.08.019_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1748-5908-5-69","article-title":"Scoping studies: advancing the methodology","volume":"5","author":"Levac","year":"2010","journal-title":"Implement Sci"},{"key":"10.1016\/j.clml.2023.08.019_bib0021","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1089\/jayao.2017.0034","article-title":"AYA-myeloma: real-world, single-center experience over last 5 years","volume":"7","author":"Yanamandra","year":"2018","journal-title":"J Adolesc Young Adult Oncol"},{"key":"10.1016\/j.clml.2023.08.019_bib0022","first-page":"79","article-title":"The outcome of autologous stem cell transplantation in adolescent and young adult patients with multiple myeloma","volume":"4","author":"Yigenoglu","year":"2020","journal-title":"Eur J Med Oncol"},{"key":"10.1016\/j.clml.2023.08.019_bib0023","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1182\/blood-2017-05-693606","article-title":"How I treat the young patient with multiple myeloma","volume":"132","author":"Gandolfi","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.clml.2023.08.019_bib0024","doi-asserted-by":"crossref","first-page":"966","DOI":"10.3109\/10428194.2013.837163","article-title":"Myeloma and pregnancy: strange bedfellows?","volume":"55","author":"Khot","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2023.08.019_bib0025","first-page":"205","article-title":"\u201cNo\u201d for the allogeneic stem cell transplantation in young patients diagnosed with multiple myeloma","volume":"68","author":"Suska","year":"2018","journal-title":"Nowotwory"},{"key":"10.1016\/j.clml.2023.08.019_bib0026","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s12185-013-1420-y","article-title":"Multiple myeloma presenting as bilateral breast lumps in pregnant woman","volume":"98","author":"Bouzguenda","year":"2013","journal-title":"Int J Hematol"},{"key":"10.1016\/j.clml.2023.08.019_bib0027","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.3109\/10428194.2013.786069","article-title":"Pregnancy and multiple myeloma are not antinomic","volume":"54","author":"Brisou","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2023.08.019_bib0028","doi-asserted-by":"crossref","DOI":"10.1177\/20406207211066173","article-title":"Diagnosis and management of multiple myeloma during pregnancy: case report, review of the literature, and an update on current treatments","volume":"13","author":"Magen","year":"2022","journal-title":"Ther Adv Hematol"},{"key":"10.1016\/j.clml.2023.08.019_bib0029","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.clml.2011.03.009","article-title":"Management of multiple myeloma in pregnancy: strategies for a rare challenge","volume":"11","author":"Kasenda","year":"2011","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.clml.2023.08.019_bib0030","first-page":"920","article-title":"Multiple myeloma during pregnancy as a challenge in clinical practice: a review","volume":"9","author":"Szyde\u0142ko","year":"2019","journal-title":"J Educ Health Sport"},{"key":"10.1016\/j.clml.2023.08.019_bib0031","first-page":"82","article-title":"Multiple myeloma in young pregnant patient","volume":"19","author":"Marouf","year":"2021","journal-title":"World Fam Med"},{"key":"10.1016\/j.clml.2023.08.019_bib0032","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/hon.2184","article-title":"Management multiple myeloma during pregnancy: a case report and review","volume":"34","author":"Cabanas-Perianes","year":"2016","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.clml.2023.08.019_bib0033","first-page":"38","article-title":"Multiple myeloma in two young postpartum women","volume":"111","author":"Harster","year":"1987","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.clml.2023.08.019_bib0034","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1002\/1097-0142(19851015)56:8<2143::AID-CNCR2820560844>3.0.CO;2-8","article-title":"Multiple myeloma in a child","volume":"56","author":"Bernstein","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2023.08.019_bib0035","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1097\/RLU.0000000000003200","article-title":"PET imaging of a unique case of multiple myeloma in an adolescent","volume":"45","author":"Binkovitz","year":"2020","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.clml.2023.08.019_bib0036","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1016\/j.clml.2014.08.004","article-title":"Multiple myeloma: a rare case in an 8-year-old child","volume":"15","author":"Crusoe","year":"2015","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.clml.2023.08.019_bib0037","doi-asserted-by":"crossref","first-page":"e27528","DOI":"10.1002\/pbc.27528","article-title":"Bone marrow transplant and pediatric multiple myeloma","volume":"66","author":"Davidow","year":"2019","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.clml.2023.08.019_bib0038","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2350\/12-05-1187-CR.1","article-title":"Plasma cell myeloma associated with Epstein-Barr virus infection in an 11-year-old girl","volume":"15","author":"Garc\u00eda-\u00c1lvarez","year":"2012","journal-title":"Pediatr Dev Pathol"},{"key":"10.1016\/j.clml.2023.08.019_bib0039","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/pbc.22812","article-title":"Nonsecretory myeloma in a child","volume":"56","author":"Gogia","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.clml.2023.08.019_bib0040","doi-asserted-by":"crossref","first-page":"441","DOI":"10.7326\/0003-4819-84-4-441","article-title":"Multiple myeloma in young persons","volume":"84","author":"Hewell","year":"1976","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clml.2023.08.019_bib0041","first-page":"225","article-title":"Clinical spectrum and prognosis of multiple myeloma in patients younger than 30 years: is it different from the elderly?","volume":"8","author":"Kapoor","year":"2006","journal-title":"JK Sci"},{"key":"10.1016\/j.clml.2023.08.019_bib0042","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/dc.20039","article-title":"Cytologic diagnosis of plasma myeloma in an 8-year-old child: case report","volume":"31","author":"Mohanty","year":"2004","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.clml.2023.08.019_bib0043","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/MPH.0000000000000684","article-title":"Multiple myeloma in an 8-year-old child with HIV infection","volume":"39","author":"Radhakrishnan","year":"2017","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.clml.2023.08.019_bib0044","first-page":"65","article-title":"Multiple myeloma in a child","volume":"37","author":"Baklanova","year":"1962","journal-title":"Vestn Rentgenol Radiol"},{"key":"10.1016\/j.clml.2023.08.019_bib0045","doi-asserted-by":"crossref","first-page":"e172","DOI":"10.1016\/j.clml.2015.07.395","article-title":"Bortezomib based regimen in young high risk multiple myeloma patients relapsed after allogeneic stem cell transplantation: two clinical cases","volume":"15","author":"Quaresima","year":"2015","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.clml.2023.08.019_bib0046","first-page":"253","article-title":"Dyspnea, massive effusion and lytic rib lesion as initial presentation of multiple myeloma in a young man","volume":"20","author":"AlShati","year":"2013","journal-title":"Can Respir J"},{"issue":"294","key":"10.1016\/j.clml.2023.08.019_bib0047","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/00003086-199309000-00042","article-title":"Multiple-myeloma in a 25-year-old woman","author":"Badwey","year":"1993","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.clml.2023.08.019_bib0048","doi-asserted-by":"crossref","first-page":"881A","DOI":"10.1378\/chest.2261097","article-title":"A rare case of IgA myelomatous pleural effusion","volume":"148","author":"Barmaimon","year":"2015","journal-title":"Chest"},{"key":"10.1016\/j.clml.2023.08.019_bib0049","doi-asserted-by":"crossref","first-page":"A1851","DOI":"10.1016\/j.chest.2019.08.1600","article-title":"A rare case of multiple solitary plasmacytomas involving the right hilum, bronchus, and lung in a 39-year-old female with multiple myeloma","volume":"156","author":"Boulos","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.clml.2023.08.019_bib0050","first-page":"177","article-title":"Aggressive multiple myeloma with brain involvement in a young patient","volume":"66","author":"Chen","year":"2003","journal-title":"J Chin Med Assoc"},{"key":"10.1016\/j.clml.2023.08.019_bib0051","first-page":"554","article-title":"Atypical presentation of multiple myeloma in young man who presented with nephrotic syndrome due only to urinary light chains","volume":"38","author":"De Galasso","year":"2014","journal-title":"Biochim Clin"},{"key":"10.1016\/j.clml.2023.08.019_bib0052","first-page":"121","article-title":"Multiple-myeloma in children and young-adults","volume":"2","author":"Decoteau","year":"1992","journal-title":"Diagn Oncol"},{"key":"10.1016\/j.clml.2023.08.019_bib0053","first-page":"289","article-title":"Case report: unusual clinical presentation of a multiple myeloma in a young patient","volume":"37","author":"Diwoky","year":"2014","journal-title":"Oncol Res Treatment"},{"key":"10.1016\/j.clml.2023.08.019_bib0054","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/ajh.25477","article-title":"Plasmacytoma presenting as jugular foramen tumor in a young woman with multiple myeloma","volume":"94","author":"How","year":"2019","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2023.08.019_bib0055","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.4103\/jfmpc.jfmpc_343_20","article-title":"An atypical presentation of multiple myeloma in a young patient with pathological fracture","volume":"9","author":"Kumar","year":"2020","journal-title":"J Family Med Prim Care"},{"key":"10.1016\/j.clml.2023.08.019_bib0056","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1002\/1097-0142(19800915)46:6<1397::AID-CNCR2820460618>3.0.CO;2-F","article-title":"Multiple myeloma in young men. Clinical course and electron microscopic studies of bone marrow plasma cells","volume":"46","author":"Lazarus","year":"1980","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2023.08.019_bib0057","article-title":"Plasma cell myeloma lytic lesions mimicking vanishing bone syndrome in a young patient","volume":"5","author":"Mwania","year":"2019","journal-title":"BJR Case Rep"},{"key":"10.1016\/j.clml.2023.08.019_bib0058","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4274\/tjem.2966","article-title":"Hypoglobulinemia and nonsecretory myeloma as a rare cause of osteoporosis in a young man","volume":"20","author":"Onba\u015f\u0131","year":"2016","journal-title":"Turk J Endocrinol Metab"},{"issue":"suppl 1","key":"10.1016\/j.clml.2023.08.019_bib0059","first-page":"94","article-title":"Mandibular lesion as the first sign of multiple myeloma in a young patient","volume":"23","author":"Pontes","year":"2019","journal-title":"J Oral Maxillofac Pathol"},{"key":"10.1016\/j.clml.2023.08.019_bib0060","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.2349\/biij.5.2.e5","article-title":"Dural plasmacytoma mimicking meningioma in a young patient with multiple myeloma","volume":"5","author":"Rahmah","year":"2009","journal-title":"Biomed Imaging Interv J"},{"key":"10.1016\/j.clml.2023.08.019_bib0061","first-page":"187","article-title":"Micromolecular multiple myeloma with chronic kidney failure in a young female patient on continuous hemodialysis","volume":"54","author":"Rotaru","year":"2013","journal-title":"Rom J Morphol Embryol"},{"key":"10.1016\/j.clml.2023.08.019_bib0062","article-title":"A rare case of renal recovery in a young patient with multiple myeloma","volume":"2013","author":"Salameh","year":"2013","journal-title":"Case Rep"},{"key":"10.1016\/j.clml.2023.08.019_bib0063","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4103\/0971-4065.125081","article-title":"Plasmablastic myeloma presenting as rapidly progressive renal failure in a young adult","volume":"24","author":"Srija","year":"2014","journal-title":"Indian J Nephrol"},{"key":"10.1016\/j.clml.2023.08.019_bib0064","first-page":"1232","article-title":"Multiple myeloma in association with light chain deposition disease in a 39-year-old: a case report","volume":"30","author":"Vanga","year":"2019","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.clml.2023.08.019_bib0065","first-page":"S423","article-title":"Bony swellings in a young male unusual presentation of multiple myeloma","volume":"32","author":"Verma","year":"2016","journal-title":"Indian J Hematol Blood Transfus"},{"key":"10.1016\/j.clml.2023.08.019_bib0066","first-page":"195","article-title":"Scleredema-associated IgA myeloma with myelofibrosis in a young adult: a case report","volume":"25","author":"Rao","year":"2008","journal-title":"Turk J Haematol"},{"key":"10.1016\/j.clml.2023.08.019_bib0067","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1532\/IJH97.06226","article-title":"Analysis of serum angiogenic factors in a young multiple myeloma patient with high-output cardiac failure","volume":"86","author":"Sasaki","year":"2007","journal-title":"Int J Hematol"},{"key":"10.1016\/j.clml.2023.08.019_bib0068","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/RHU.0b013e3181b0fe1e","article-title":"Multiple myeloma and systemic lupus erythematosus in a young woman","volume":"15","author":"Okoli","year":"2009","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.clml.2023.08.019_bib0069","doi-asserted-by":"crossref","first-page":"69","DOI":"10.14740\/jh380w","article-title":"A rare case of early onset multiple myeloma in a 20-year-old female with factor X inhibitor","volume":"7","author":"Mufti","year":"2018","journal-title":"J Hematol (Brossard)"},{"key":"10.1016\/j.clml.2023.08.019_bib0070","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1182\/blood-2011-06-362905","article-title":"A young patient with multiple myeloma","volume":"119","author":"Munoz","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.clml.2023.08.019_bib0071","article-title":"A 30-year-old carrier of Gaucher disease with multiple myeloma","volume":"2019","author":"Chadha","year":"2019","journal-title":"Case Rep Oncol Med"},{"key":"10.1016\/j.clml.2023.08.019_bib0072","first-page":"S601","article-title":"Painting the big M","volume":"34","author":"Berenji","year":"2019","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.clml.2023.08.019_bib0073","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/cncr.22850","article-title":"Epidemiology of multiple myeloma in Taiwan: increasing incidence for the past 25 years and higher prevalence of extramedullary myeloma in patients younger than 55 years","volume":"110","author":"Huang","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2023.08.019_bib0074","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.bbmt.2009.02.013","article-title":"Age 40 years and under does not confer superior prognosis in patients with multiple myeloma undergoing upfront autologous stem cell transmplant","volume":"15","author":"Cheema","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.clml.2023.08.019_bib0075","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.3324\/haematol.2013.098608","article-title":"Age is a prognostic factor even among patients with multiple myeloma younger than 66 years treated with high-dose melphalan: the IFM experience on 2316 patients","volume":"99","author":"Chretien","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2023.08.019_bib0076","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/bjh.14328","article-title":"Characteristics and outcomes of patients with multiple myeloma aged 21\u201340 years versus 41\u201360 years: a multi-institutional case-control study","volume":"175","author":"Jurczyszyn","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2023.08.019_bib0077","first-page":"506","article-title":"Effect of age in autologous stem cell transplantation in patients with multiple myeloma: experience of a single center","volume":"54","author":"M\u00e1rquez","year":"2019","journal-title":"Bone Marrow Transplant"},{"issue":"suppl 2","key":"10.1016\/j.clml.2023.08.019_bib0078","first-page":"201","article-title":"Patients with multiple myeloma and younger than 50 years have a superior overall survival after first-line high-dose chemotherapy followed by autologous stem cell transplantation. Results of a retrospective, single-centre analysis","volume":"44","author":"Mohring","year":"2021","journal-title":"Oncol Res Treatment"},{"key":"10.1016\/j.clml.2023.08.019_bib0079","doi-asserted-by":"crossref","first-page":"S252","DOI":"10.1016\/j.bbmt.2010.12.302","article-title":"Transplant outcomes in multiple myeloma patients younger versus older than 60 years of age in the era of newer targeted agents","volume":"17","author":"Naik","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.clml.2023.08.019_bib0080","doi-asserted-by":"crossref","first-page":"S386","DOI":"10.1016\/j.bbmt.2018.12.794","article-title":"A single institution retrospective analysis of outcomes in multiple myeloma patients aged 50 and younger undergoing autologous HCT","volume":"25","author":"Patibandla","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.clml.2023.08.019_bib0081","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1002\/cncr.22660","article-title":"Limited feasibility of double transplant in multiple myeloma: results of a multicenter study on 153 patients aged <65 years","volume":"109","author":"Corso","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2023.08.019_bib0082","first-page":"S300","article-title":"Tandem autologous plus reduced-intensity allogeneic stem cell transplantation without standard immunosuppression in young patients with relapsed and refractory multiple myeloma","volume":"50","author":"Pokrovskaya","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clml.2023.08.019_bib0083","first-page":"233","article-title":"Tandem autologous hematopoietic stem cell transplantation in very young patients with multiple myeloma","volume":"9","author":"Naithani","year":"2020","journal-title":"South Asian J"},{"key":"10.1016\/j.clml.2023.08.019_bib0084","first-page":"118","article-title":"Safety and prognosis of allogeneic stem cell transplantation in younger patients with multiple myeloma","volume":"96","author":"Xeng","year":"2016","journal-title":"Natl Med J China"},{"key":"10.1016\/j.clml.2023.08.019_bib0085","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1182\/blood.V122.21.2136.2136","article-title":"Survival outcomes of very young (<40 years) myeloma patients","volume":"122","author":"Painuly","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.clml.2023.08.019_bib0086","first-page":"743","article-title":"Presenting features at diagnosis of multiple myeloma in an Israeli cohort: patients younger than age 50 years represent a special group with a high frequency of t (11; 14)","volume":"100","author":"Duek","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2023.08.019_bib0087","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000507414","article-title":"Multiple myeloma presenting in patients younger than 50 years of age: a single institution experience","volume":"144","author":"Duek","year":"2021","journal-title":"Acta Haematol"},{"key":"10.1016\/j.clml.2023.08.019_bib0088","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1182\/blood.V124.21.2059.2059","article-title":"Impact of novel agents on young patients with T(11;14) multiple myeloma","volume":"124","author":"Paludo","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.clml.2023.08.019_bib0089","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1182\/blood.V120.21.933.933","article-title":"1P22 and 1P32 deletions are independent prognosis factors in young patients with myeloma: the IFM experience on 1195 patients","volume":"120","author":"Hebraud","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.clml.2023.08.019_bib0090","first-page":"4381","article-title":"Age related distribution of cytogenetic abnormalities in multiple myeloma","volume":"130","author":"Jaramillo","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.clml.2023.08.019_bib0091","first-page":"581","article-title":"The development of multiple myeloma in the young patients is associated with the presence of KIR3DS1 with HLA-BW4 ILE80","volume":"79","author":"Sokolova","year":"2012","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.clml.2023.08.019_bib0092","first-page":"953","article-title":"High-risk young multiple myeloma patients treated up-front with lenalidomide: impact of KIR 3DL1-EDU and KIR haplotypes on clinical outcome","volume":"2","author":"Puglisi","year":"2018","journal-title":"HemaSphere"},{"key":"10.1016\/j.clml.2023.08.019_bib0093","doi-asserted-by":"crossref","first-page":"4869","DOI":"10.1182\/blood.V104.11.4869.4869","article-title":"Interleukin-10(IL-10)1082-A and tumor necrosis factor(TNF)-Alpha 238\/308A genotypes are associated with earlier (Younger than 55) onset of multiple myeloma","volume":"104","author":"Beksac","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.clml.2023.08.019_bib0094","first-page":"156","article-title":"Serum cytokines expression in young patients with MGUS and in multiple myeloma patients treated with bortezomid combination regimens","volume":"94","author":"Buquicchio","year":"2009","journal-title":"Haematologica"},{"issue":"15 suppl","key":"10.1016\/j.clml.2023.08.019_bib0095","article-title":"Race as a predictor of outcome in young patients with myeloma","volume":"39","author":"Cottini","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clml.2023.08.019_bib0096","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1080\/10428190600647723","article-title":"multiple myeloma in young patients: a distinct entity with favorable prognosis","volume":"47","author":"Dimopoulos","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2023.08.019_bib0097","first-page":"S193","article-title":"The patients of age 45 years and under with multiple myeloma not confer superior survival","volume":"13","author":"Lu","year":"2013","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.clml.2023.08.019_bib0098","doi-asserted-by":"crossref","first-page":"i360","DOI":"10.1093\/ndt\/gfy104.SP043","article-title":"Multiple myeloma in young patients","volume":"33","author":"Mejbar","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.clml.2023.08.019_bib0099","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1182\/blood-2020-137182","article-title":"Clinical pattern and treatment outcome of 43 patients with multiple myeloma at age of 22-50 (experience from Qatar)","volume":"136","author":"Elsabah","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.clml.2023.08.019_bib0100","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s12288-021-01410-3","article-title":"Multiple myeloma in young adults: a single centre real world experience","volume":"37","author":"Pydi","year":"2021","journal-title":"Indian J Hematol Blood Transfus"},{"key":"10.1016\/j.clml.2023.08.019_bib0101","doi-asserted-by":"crossref","first-page":"722","DOI":"10.3904\/kjim.2016.256","article-title":"Clinicopathological characteristics of extremely young Korean multiple myeloma patients: therapeutic implications","volume":"32","author":"Shin","year":"2017","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.clml.2023.08.019_bib0102","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4274\/imj.galenos.2021.62593","article-title":"Subgroup analysis in multiple myeloma patients under sixty years: a single-center study","volume":"22","author":"Serin","year":"2021","journal-title":"Istanb Med J"},{"key":"10.1016\/j.clml.2023.08.019_bib0103","doi-asserted-by":"crossref","first-page":"4039","DOI":"10.1182\/blood-2007-03-081018","article-title":"Myeloma in patients younger than age 50 years presents with more favorable features and shows better survival: an analysis of 10 549 patients from the International Myeloma Working Group","volume":"111","author":"Ludwig","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.clml.2023.08.019_bib0104","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1182\/blood-2020-136399","article-title":"Multiple myeloma in adolescent and young adults: a SEER and CIBMTR analysis","volume":"136","author":"Gibson","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.clml.2023.08.019_bib0105","doi-asserted-by":"crossref","first-page":"e19512","DOI":"10.1200\/JCO.2017.35.15_suppl.e19512","article-title":"Unusual disease characteristics of multiple myeloma in eastern North Carolina","volume":"35","author":"Addepalli","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clml.2023.08.019_bib0106","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1182\/blood-2019-124301","article-title":"Evolving real-world treatment patterns in patients with newly-diagnosed multiple myeloma (NDMM) in the United States (U.S.)","volume":"134","author":"Ailawadhi","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.clml.2023.08.019_bib0107","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3324\/haematol.13782","article-title":"Expected long-term survival of patients diagnosed with multiple myeloma in 2006-2010","volume":"94","author":"Brenner","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2023.08.019_bib0108","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1002\/cncr.30183","article-title":"Impact of marital status, insurance status, income, and race\/ethnicity on the survival of younger patients diagnosed with multiple myeloma in the United States","volume":"122","author":"Costa","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2023.08.019_bib0109","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.3109\/10428194.2014.897700","article-title":"Disease-specific survival for patients with multiple myeloma: significant improvements over time in all age groups","volume":"55","author":"Libby","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2023.08.019_bib0110","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1182\/blood.V126.23.1783.1783","article-title":"In-hospital complications and mortality after autologous peripheral blood stem cell transplantation in older vs. younger multiple myeloma patients: an analysis of the national inpatient sample","volume":"126","author":"Sanchez","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.clml.2023.08.019_bib0111","first-page":"A7","article-title":"First-line treatment patterns among younger versus older patients newly diagnosed with multiple myeloma in the US","volume":"20","author":"Yong","year":"2017","journal-title":"Value Health"},{"key":"10.1016\/j.clml.2023.08.019_bib0112","doi-asserted-by":"crossref","first-page":"e213","DOI":"10.1016\/j.clml.2019.09.354","article-title":"Pacific Islanders with multiple myeloma are younger and have inferior survival when compared to other ethnicities: a study from the Australian and New Zealand Myeloma and Related Diseases Registry (MRDR)","volume":"19","author":"Blacklock","year":"2019","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.clml.2023.08.019_bib0113","first-page":"7","article-title":"Impact on survival of high-dose therapy with autologous stem cell support in patients younger than 60 years with newly diagnosed multiple myeloma: a population-based study. Nordic Myeloma Study Group","volume":"95","author":"Lenhoff","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.clml.2023.08.019_bib0114","first-page":"1228","article-title":"Intensive therapy for multiple myeloma in patients younger than 60 years. Long-term results focusing on the effect of the degree of response on survival and relapse pattern after transplantation","volume":"91","author":"Lenhoff","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2023.08.019_bib0115","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ejca.2009.07.006","article-title":"Improved survival among younger but not among older patients with multiple myeloma in the Netherlands, a population-based study since 1989","volume":"46","author":"Schaapveld","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clml.2023.08.019_bib0116","first-page":"S217","article-title":"Increased incidence of myeloma patients aged less than 35 years-a single center study","volume":"13","author":"Straub","year":"2013","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.clml.2023.08.019_bib0117","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/S1557-9190(11)70463-2","article-title":"Improved survival in younger patients with multiple myeloma: a population-based study from Malmo, Sweden","volume":"9","author":"Turesson","year":"2009","journal-title":"Clin Lymphoma Myeloma"},{"key":"10.1016\/j.clml.2023.08.019_bib0118","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s00277-014-2264-0","article-title":"Elderly multiple myeloma patients experience less deterioration in health-related quality of life than younger patients compared to a normative population: a study from the population-based PROFILES registry","volume":"94","author":"van der Poel","year":"2015","journal-title":"Ann Hematol"},{"key":"10.1016\/j.clml.2023.08.019_bib0119","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1182\/blood-2020-142066","article-title":"Assessment of 1112 newly diagnosed multiple myeloma patients according to age and year of diagnosis at a referral cancer center","volume":"136","author":"Vasquez","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.clml.2023.08.019_bib0120","doi-asserted-by":"crossref","first-page":"S137","DOI":"10.1016\/S2152-2650(21)02310-7","article-title":"P-183: clinical characteristics and outcomes in multiple myeloma patients younger than 40 years in a non-Caucasian population","volume":"21","author":"Vasquez","year":"2021","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.clml.2023.08.019_bib0121","first-page":"998","article-title":"Young adults with multiple myeloma-unveiling a different spectrum in a resource constrained setting","volume":"2","author":"Mirgh","year":"2018","journal-title":"HemaSphere"},{"key":"10.1016\/j.clml.2023.08.019_bib0122","first-page":"S139","article-title":"Impact of novel agents on survival outcome of young patients with multiple myeloma (MM)","volume":"96","author":"Kapoor","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2023.08.019_bib0123","first-page":"S160","article-title":"Outcomes of young patients (50 years or below) with multiple myeloma (MM)","volume":"13","author":"Kapoor","year":"2013","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.clml.2023.08.019_bib0124","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.1182\/blood.V120.21.4030.4030","article-title":"Survival until first progression and post first progression survival equally contribute to the overall survival of myeloma patients: differences in patients 65 years of age compared to patients >65 years","volume":"120","author":"Kastritis","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.clml.2023.08.019_bib0125","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.2147\/DDDT.S100062","article-title":"More frequent IgD and reduced CD200 expression in Chinese patients younger than 50 years old with multiple myeloma: a multicenter analysis","volume":"10","author":"Lu","year":"2016","journal-title":"Drug Design Dev Ther"},{"key":"10.1016\/j.clml.2023.08.019_bib0126","first-page":"531","article-title":"A study of the clinicopathologic features of multiple myeloma in young patients","volume":"30","author":"Palta","year":"2014","journal-title":"Indian J Hematol Blood Transfus"},{"key":"10.1016\/j.clml.2023.08.019_bib0127","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41408-018-0065-8","article-title":"Defining cure in multiple myeloma: a comparative study of outcomes of young individuals with myeloma and curable hematologic malignancies","volume":"8","author":"Ravi","year":"2018","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.clml.2023.08.019_bib0128","first-page":"267","article-title":"An exploration of the lived experiences of individuals with relapsed multiple myeloma","volume":"20","author":"Maher","year":"2011","journal-title":"Eur J Cancer Care (Engl)"},{"key":"10.1016\/j.clml.2023.08.019_bib0129","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/s12885-019-5467-x","article-title":"Treatment preferences of patients with relapsed and refractory multiple myeloma: a qualitative study","volume":"19","author":"Parsons","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clml.2023.08.019_bib0130","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3892\/mco.2015.658","article-title":"Novel agent induction therapy alone or followed by autologous stem cell transplantation in younger patients with multiple myeloma: a single\u2011center retrospective study of 114 cases","volume":"4","author":"Wang","year":"2016","journal-title":"Mol Clin Oncol"},{"key":"10.1016\/j.clml.2023.08.019_bib0131","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1200\/JCO.2009.25.4177","article-title":"Patterns of improved survival in patients with multiple myeloma in the twenty-first century: a population-based study","volume":"28","author":"Turesson","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clml.2023.08.019_bib0132","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/0165025414533223","article-title":"Midlife as a pivotal period in the life course: balancing growth and decline at the crossroads of youth and old age","volume":"39","author":"Lachman","year":"2015","journal-title":"Int J Behav Dev"},{"key":"10.1016\/j.clml.2023.08.019_bib0133","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1037\/amp0000591","article-title":"Midlife in the 2020s: opportunities and challenges","volume":"75","author":"Infurna","year":"2020","journal-title":"Am Psychol"},{"key":"10.1016\/j.clml.2023.08.019_bib0134","doi-asserted-by":"crossref","first-page":"e360","DOI":"10.1200\/OP.21.00288","article-title":"Development of the oncology opportunity cost assessment tool: item generation and content validity testing","volume":"18","author":"Handley","year":"2022","journal-title":"JCO Oncol Pract"},{"key":"10.1016\/j.clml.2023.08.019_bib0135","doi-asserted-by":"crossref","first-page":"e1494","DOI":"10.1200\/OP.22.00056","article-title":"Financial toxicity intervention improves outcomes in patients with hematologic malignancy","volume":"18","author":"Knight","year":"2022","journal-title":"JCO Oncol Pract"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S215226502300277X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S215226502300277X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:43:40Z","timestamp":1761871420000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S215226502300277X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":135,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S215226502300277X"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2023.08.019","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multiple Myeloma in Young Patients: A Scoping Review","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2023.08.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}